The death rate did significantly decrease in patients with less severe non-ST elevation heart attacks from 10% to 7.6%.
在伴不严重非st段抬高型心肌梗死的人们中，死亡率显著下降，从10%到7.6%。
Objective: To observe the clinical effect and safety in treatment of non-ST elevation myocardial infarction (NSTEMI) with clopidogrel.
目的：观察氯吡格雷治疗急性非st段抬高心肌梗死(NSTEMI)的临床疗效及安全性。
BNP is also increased during non-ST elevation acute coronary syndrome, indicating that BNP level may be associated with the scope of ischemia and the severity of disease.
非st段抬高急性冠脉综合征患者BNP水平也增高，表明BNP水平与缺血的范围以及严重程度有关联。
A comparison of st elevation versus non-ST elevation myocardial infarction outcomes in a large registry database: Are non-ST myocardial infarctions associated with worse long-term prognoses?
一项大型注册研究数据库中ST段抬高和非st段抬高心肌梗死转归的比较：非st段抬高心肌梗死是否与更差的远期预后相关？
Conclusion Detection of plasma BNP has prognosis value in the patients with non ST segment elevation ACS.
结论血浆BNP检测对无st段抬高的ACS患者预后有较好的判断价值。
Objective There have been many controversies on the value of percutaneous coronary intervention (PCI) in patients of non-ST-segment elevation ACS.
目的： 长期以来，介入治疗在非ST段抬高的急性冠脉综合症（ACS）患者的价值方面，意见不一。
Objectives: the goal of this work was to explore the treatment and outcomes of patients with non-st-segment elevation acute coronary syndromes (NSTE-ACS) age 90 years.
目的：本研究旨在探讨90岁以上非st段抬高急性冠脉综合征(NSTE - ACS)患者的治疗措施及预后。
Objective:To study the characteristics of arrhythmias in patients with acute ST segment elevation myocardial infarction(STEMI) and non-ST segment elevation myocardial infarction(NSTEMI).
目的：对比分析急性ST段抬高性心肌梗死与非ST段抬高性心肌梗死患者并发心律失常的特点。
Objective:To investigate the Xuefu Zhuyu Tang(XZT) treatment of non-ST segment elevation Acute Coronary Syndrome(NEST-ACS) and its impact on the effects of Inflammatory factors.
目的：探讨血府逐瘀汤治疗非ST段抬高型急性冠脉综合征（NEST-ACS）的临床疗效及其对炎症因子的影响。
Conclusion: Reperfusion treatment may reduce the mortality of non-ST-elevation acute coronary infarction and the incidence of events in hospital.
结论：再灌注治疗可以降低急性ST段抬高心梗的住院死亡率，减少住院不良事件的发生。
The researchers determined the GRACE risk score in 681 non-ST-elevation ACS patients enrolled in a treatment trial.
研究者检查了治疗实验中681名无st段抬高的急性冠脉综合征病人的GRACE危险分数。
The CRUSADE initiative included high-risk patients with unstable angina and non–ST-segment elevation myocardial infarction (NSTEMI).
CRUSADE入选包括高危不稳定性心绞痛和非ST段抬高心梗患者。
Objective To investigate the rapid determination of brain natriuretic peptide (BNP) in the early diagnosis of non-ST-segment elevation acute myocardial infarction (NSTEMI) value.
目的探讨快速测定脑钠肽(BNP)在早期诊断非st段抬高急性心肌梗死(NSTEMI)中的价值。
Objective To compare the safety of 2 unfractionated heparin regimens during PCI in high-risk patients with non–ST-segment elevation acute coronary syndromes initially treated with fondaparinux.
目的：比较在用磺达肝素治疗过的非ST段抬高性急性冠脉综合症的高危患者行PCI时使用的两种不同剂量普通肝素的安全性。
After other conditions had been ruled out he was diagnosed with acute non-ST-elevation myocardial infarction.
其他条件后，已排除了他被确诊为急性非st段抬高心肌梗死。
Results: Reperfusion treatment was the major methods on non-ST-elevation acute coronary infarction.
结果：再灌注治疗是急性ST段抬高心梗治疗的主要方法。
Results: Reperfusion treatment was the major methods on non-ST-elevation acute coronary infarction.
结果：再灌注治疗是急性ST段抬高心梗治疗的主要方法。
应用推荐